Innovative mRNA therapeutics based on next-generation cap analogs

ExploRNA Therapeutics Sp. z o.o.
Biopharma Dealmakers · Springer Nature · 2025-12-01 · DOI: 10.1038/d43747-025-00106-1

Abstract

Biopharma Dealmakers, Published online: 01 December 2025; doi:10.1038/d43747-025-00106-1 ExploRNA Therapeutics’ biologically inspired, ground-breaking technologies are enabling more precise customization of mRNA constructs with advanced vaccine and therapeutic applications.

Read at publisher →

Similar articles